ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Radius Health Announces Acquisition of Orphan Disease Program
January 14, 2021Radius Health announced a definitive agreement to acquire the global development and commercialization rights to Benuvia Therapeutics (Benuvia) synthetic cannabidiol oral solution (RAD011). -
Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada
January 13, 2021Radius Health has entered into definitive agreements with Endo Ventures Limited, a subsidiary of Endo International, to register, commercialize, and distribute abaloparatide on an exclusive basis in Canada. -
Radius Health & Menarini Group Provide Elacestrant Update
September 27, 2020Radius Health, Inc. and the Menarini Group announced an update on the elacestrant Phase 3 EMERALD trial.
Pharma Sources Insight January 2025
